CureVac says low-dose coronavirus vaccine could allow for mass production

22:12 15/03/2020
Germany’s CureVac, among the vaccine developers funded by the Coalition for Epidemic Preparedness Innovations (CEPI), said it could mass-produce a coronavirus immunization from its existing facilities if its low-dose approach proves successful in trials.
Leave your comment